3D Systems Achieves Full-Scope EU MDR Certification, Accelerating European Launch of NextDent® Jetted Denture Solution Targeted for Summer 2026

Rhea-AI Summary

3D Systems (NYSE: DDD) received full-scope EU MDR certification on March 17, 2026, clearing regulatory hurdles to sell MDR-compliant dental products in Europe. The certification enables a phased European rollout and supports the planned summer 2026 launch of the NextDent Jetted Denture Solution.

Company estimates an addressable U.S. 'replacement' market of about $600 million by 2029 and cites potential annual recurring materials revenue of > $400 million globally as digital adoption grows.

Positive

• EU MDR certification attained on March 17, 2026 enabling EU market access
• NextDent Jetted Denture EU launch targeted for summer 2026
• Company estimates $600M U.S. addressable market for replacement pillar by 2029
• Materials represent potential > $400M annual recurring revenue opportunity globally

Negative

• None.

News Market Reaction – DDD

+1.93%

1 alert

+1.93% News Effect

On the day this news was published, DDD gained 1.93%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

U.S. replacement TAM: $600 million U.S. share of global market: one-third U.S. denture wearers: 32 million people +5 more

8 metrics

U.S. replacement TAM $600 million Addressable U.S. market for ‘replacement’ pillar by 2029

U.S. share of global market one-third Company estimate of U.S. share of total global replacement market

U.S. denture wearers 32 million people Approximate denture wearers in United States (~10% of population)

Global denture wearers more than 180 million people Estimated global denture-wearing population

Annual denture sets approximately 13.7 million Estimated annual production of denture sets globally

Materials ARR opportunity more than $400 million Potential annual recurring revenue from dental materials globally over time

Clear aligners output approximately one million daily Patient-specific clear aligners manufactured daily using 3D Systems solutions

EU MDR regulation 2017/745 European Union Medical Device Regulation reference number cited for certification

Market Reality Check

Price: $1.8900 Vol: Volume 2914139 is below t...

normal vol

$1.8900 Last Close

Volume Volume 2914139 is below the 20-day average of 3383352, suggesting no outsized positioning ahead of this news. normal

Technical Shares at 2.07 are trading below the 200-day MA of 2.2, and remain 45.53% under the 52-week high of 3.8 despite recent strength.

Peers on Argus

Pre-news, DDD showed a modest uptick while peers were mixed: NNDM was up 3.61, b...

1 Up

Pre-news, DDD showed a modest uptick while peers were mixed: NNDM was up 3.61, but OSS, UMAC, QMCO, and CAN showed negative single‑digit moves. Only CAN appeared in the momentum scanner, so this looks more company-specific than a broad hardware or 3D-printing move.

Historical Context

5 past events · Latest: Mar 23 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 23	CFO appointment	Positive	+5.7%	New permanent CFO appointed, reinforcing financial leadership continuity.
Mar 09	Earnings release	Positive	+28.1%	Q4 revenue growth, cost savings, and GAAP profitability highlighted in results.
Mar 02	Earnings date set	Neutral	-0.5%	Announcement of timing and access details for upcoming earnings call.
Feb 18	Product expansion	Positive	+0.0%	New NextDent denture base shades added to enhance aesthetics and flexibility.
Jan 05	Conference appearance	Positive	+11.6%	Participation in Needham Growth Conference via CEO and finance leadership.

Pattern Detected

Recent company-specific announcements, especially earnings and leadership updates, have often coincided with positive price reactions, while some product news drew limited immediate response.

Recent Company History

In the last few months, 3D Systems has combined strategic updates with dental-focused product expansion. The Q4 and full-year 2025 results on March 9, 2026 drove a 28.06% move, contrasting weaker full-year revenue but highlighting cost savings and profitability. The Needham conference appearance on January 5, 2026 and the CFO appointment on March 23, 2026 both saw double- and mid-single-digit gains. Earlier enhancements to the NextDent Jetted Denture Solution drew no immediate move, so today’s EU MDR milestone builds on that dental strategy.

Market Pulse Summary

This announcement underscores 3D Systems’ strategic push in digital dentistry, adding full-scope EU ...

Analysis

This announcement underscores 3D Systems’ strategic push in digital dentistry, adding full-scope EU MDR certification to support the NextDent Jetted Denture rollout in Europe by summer 2026. Management cites a U.S. replacement market of $600 million by 2029 and a global materials opportunity above $400 million, alongside more than 180 million denture wearers worldwide. In context of recent strong Q4 2025 results and ongoing dental product expansion, investors may watch adoption trends, regulatory milestones, and execution on phased European deployment.

Key Terms

eu mdr, medical device regulation, stereolithography (sla), multijet printing, +1 more

5 terms

eu mdr regulatory

"received full-scope certification under the European Union Medical Device Regulation (EU MDR) 2017/745"

The EU MDR is the European Union’s set of rules governing the safety, testing and approval of medical devices sold in the EU, replacing older standards with stricter requirements for clinical evidence, traceability and post‑market checks. For investors it matters because the regulation affects how quickly products can reach patients, the cost of compliance and the risk of sales delays or recalls—think of it as a building code that can slow or speed a company’s ability to open new properties.

medical device regulation regulatory

"full-scope certification under the European Union Medical Device Regulation (EU MDR) 2017/745"

Rules and processes governments require for making, testing, approving, and monitoring medical devices so they are safe and work as intended. Think of it like a building code and inspection process for devices: meeting these rules can be costly and slow but opens markets and reduces the risk of recalls and legal trouble, while failure to comply can cut revenue, delay product launches, or cause fines—issues investors watch closely.

stereolithography (sla) technical

"high-volume manufacturing stereolithography (SLA) technology, the Company’s solutions enable the manufacture"

Stereolithography (SLA) is a 3D printing process that builds precise objects by hardening liquid resin one thin layer at a time using a focused light source, like drawing each layer of a sculpture with a laser. For investors, SLA matters because it enables faster prototyping, high-detail production and lower tooling costs for products ranging from medical devices to consumer goods, which can speed time-to-market, affect manufacturing margins and create competitive or regulatory advantages.

multijet printing technical

"production efficiency using our MultiJet Printing technology. With strong early traction"

A 3D production method that works like an inkjet printer building upward: tiny droplets of liquid material are jetted and hardened layer by layer, often from multiple print heads or with different materials at once to create complex, multi-material parts. Investors should care because multijet printing enables faster prototyping, customized or small-batch production, and simpler supply chains, which can lower costs, shorten time to market and open new product lines with less capital investment.

biocompatible medical

"NextDent’s pioneering biocompatible 3D printing resins. NextDent, originally launched in 2012"

A biocompatible material or product can be placed in or used on the human body without causing harmful reactions, irritation, or rejection; it’s the quality that allows medical devices, implants, or drug-delivery systems to coexist safely with tissues and bodily fluids. Investors care because proven biocompatibility is a key hurdle for regulatory approval, patient and clinician acceptance, and lower recall or liability risk—like clothing that won’t irritate skin, it helps products reach the market faster and sell more reliably.

AI-generated analysis. Not financial advice.

Certification Marks Major Milestone in Strategic Dental Growth Initiative Addressing Straightening, Protection, Repair and Replacement of Teeth

ROCK HILL, S.C., March 25, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE: DDD) today announced it has received full-scope certification under the European Union Medical Device Regulation (EU MDR) 2017/745. The certification was attained on Monday, March 17, 2026.

This milestone confirms that the Company’s quality system, technical documentation, and clinical evidence meet the most rigorous regulatory requirements in the medical device sector. With the MDR certificate in hand, 3D Systems will now introduce MDR-compliant product versions through a carefully coordinated, phased rollout across its dental product families and European markets. This approach ensures a smooth transition while maintaining uninterrupted product availability for customers and healthcare providers.

The EU MDR certification immediately enables the introduction of innovative new materials and is a pivotal step for one of 3D Systems’ largest potential new product launches: the NextDent® Jetted Denture Solution. This solution forms the cornerstone of the Company’s ‘replacement’ offering within its comprehensive digital dentistry strategy, which spans applications for straightening, protection, repair, and full replacement of teeth.

Building on the successful U.S. commercial launch in 2025, this European rollout positions 3D Systems to capture additional share in a substantial global opportunity. According to the Company’s internal estimates, applications for the ‘replacement’ pillar of its dental strategy represent an addressable market of approximately $600 million in the United States alone by 2029, with the U.S. comprising roughly one-third of the total global market. The market in the EU is estimated to be comparable, or even slightly larger in scale than that of the U.S., based on Company analysis and demographic trends. As highlighted by President and CEO, Dr. Jeffrey Graves, during the Company’s Q4 2025 earnings call on March 9, 2026, approximately 32 million people in the United States wear dentures, roughly 10% of the population, and globally more than 180 million people wear dentures, driving annual production of approximately 13.7 million denture sets. Management further noted that 3D Systems’ materials alone represent a potential annual recurring revenue opportunity of more than $400 million globally over time, as digital manufacturing adoption accelerates.

The European launch of NextDent Jetted Dentures remains firmly on track for summer 2026.

3D Systems has long held a leadership position in digital dentistry, particularly in orthodontic aligner production.

Through its longstanding partnership with major industry players and the deployment of application specific high-volume manufacturing stereolithography (SLA) technology, the Company’s solutions enable the manufacture of approximately one million patient-specific clear aligners daily worldwide, establishing it as a key enabler in the straightening segment of the market.

This leadership builds on the 2017 acquisition of Vertex Global Holding B.V., which brought together Vertex Dental’s decades-long legacy in high-quality prosthetic dental materials (dating back to its founding in 1939) with NextDent’s pioneering biocompatible 3D printing resins. NextDent, originally launched in 2012 to advance materials for emerging 3D printing innovations in dentistry, has since developed one of the industry’s broadest portfolios of clinically validated, regulatory-approved materials, addressing applications from models and surgical guides to splints, crowns, bridges, and dentures. The integration of these advanced Vertex and NextDent materials with 3D Systems’ printing platforms has driven transformative efficiency, precision, and cost reductions across dental workflows.

“Receiving full-scope EU MDR certification validates our commitment to the highest standards of quality and patient safety while unlocking significant new growth opportunities across the European dental market,” said Jeffrey Graves, President and Chief Executive Officer of 3D Systems. “Building on our established dominance in high-volume aligner production and the industry-leading NextDent materials portfolio from our Vertex acquisition, the NextDent Jetted Denture Solution represents a transformative advancement in delivering monolithic, multi-material prosthetics with superior aesthetics, durability, and production efficiency using our MultiJet Printing technology. With strong early traction in the U.S. and the substantial addressable market we outlined in our recent earnings call, this launch accelerates momentum in our dental business, one of our most significant growth initiatives, and reinforces its role as a key driver of long-term shareholder value. We are excited about these accomplishments and the substantial business opportunities they generate.”

Powered by the NextDent 300 MultiJet 3D printer and specialized NextDent Jet Base and Teeth materials, the solution enables dental labs to produce durable, aesthetically superior, one-piece dentures far faster and more cost-effectively than traditional analog methods. This delivers both outstanding patient outcomes and strong return on investment for labs and clinicians.

This regulatory achievement further solidifies 3D Systems’ leadership position in digital dentistry and supports the Company’s broader strategic initiatives to expand in high-value healthcare applications.

About 3D Systems For nearly 40 years, Chuck Hull’s curiosity and desire to improve the way products were designed and manufactured gave birth to 3D printing, 3D Systems, and the additive manufacturing industry. Since then, that same spark continues to ignite the 3D Systems team as we work side-by-side with our customers to change the way industries innovate. As a full-service solutions partner, we deliver industry-leading 3D printing technologies, materials and software to high-value markets such as medical and dental; aerospace, space and defense; transportation and motorsports; AI infrastructure; and durable goods. Each application-specific solution is powered by the expertise and passion of our employees who endeavor to achieve our shared goal of Transforming Manufacturing for a Better Future. More information on the Company is available at www.3dsystems.com.

Forward-Looking Statements Certain statements in this press release are forward-looking, including statements regarding the timing of product launches, regulatory timelines, market opportunities, and the expected impact on growth and shareholder value. Actual results may differ materially due to risks and uncertainties detailed in the Company’s SEC filings. 3D Systems undertakes no obligation to update any forward-looking statements.

Investor Contact: investor.relations@3dsystems.com

Media Contact: press@3dsystems.com

FAQ

What does 3D Systems (DDD) EU MDR certification mean for the NextDent Jetted Denture Solution?

It authorizes MDR-compliant product introduction across Europe, enabling regulated sales and distribution. According to the company, the certification (attained March 17, 2026) permits a phased EU rollout and supports the summer 2026 commercial launch.

When will 3D Systems (DDD) launch NextDent Jetted Dentures in Europe?

The European rollout is scheduled for summer 2026. According to the company, the launch follows full-scope EU MDR certification and will use a coordinated, phased approach to maintain product availability.

How large is the market opportunity cited by 3D Systems (DDD) for denture replacement?

The company estimates an addressable U.S. replacement market of about $600 million by 2029. According to the company, the EU market is comparable or slightly larger based on demographic analysis.

What revenue potential did 3D Systems (DDD) outline for NextDent materials?

Management cites potential annual recurring materials revenue of more than $400 million globally over time. According to the company, this assumes accelerating adoption of digital dental manufacturing.

How does EU MDR certification affect 3D Systems (DDD) competitive position in digital dentistry?

Certification strengthens regulatory credibility and enables new material introductions in Europe. According to the company, this reinforces its leadership in aligners and supports expansion into full replacement prosthetics.